Jens Lundgren

Jens Lundgren

Clinical Professor

Member of:

  • Internal medicine: infection medicine

ORCID: 0000-0001-8901-7850

Publication year:
All
1 - 18 out of 18Page size: 500
  1. 2003
  2. Published

    A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors

    Kirk, O., Lundgren, Jens, Pedersen, C., Mathiesen, L. R., Nielsen, H., Katzenstein, T. L., Obel, N. & Gerstoft, J., 2003, In: Antiviral Therapy. 8, 6, p. 595-602 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    An objective case definition of lipodystrophy in HIV-infected adults: a case-control study

    Carr, A., Emery, S., Law, M., Puls, R., Lundgren, Jens & Powderly, W., 2003, In: Lancet.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Anemia and survival in human immunodeficiency virus.

    Lundgren, Jens & Mocroft, A., 2003, In: Clinical Infectious Diseases. 37 Suppl 4, p. 297-303 7 p.

    Research output: Contribution to journal › Journal article › Research

  5. Published

    Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.

    Friis-Møller, N., Weber, R., Reiss, P., Thiébaut, R., Kirk, O., d'Arminio Monforte, A., Pradier, C., Morfeldt, L., Mateu, S., Law, M., El-Sadr, W., De Wit, S., Sabin, C. A., Phillips, A. N. & Lundgren, Jens, 2003, In: AIDS. 17, 8, p. 1179-1193 15 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Changes in viral load in people with virological failure who remain o­n the Same HAART regimen

    Cozzi-Lepri, A., Phillips, A., Miller, V., Katlama, C., Ledergerber, B., Vella, S., Weber, J., Bruun, J., Kirk, O., Clotet, B. & Lundgren, Jens, 2003, In: Antiviral Therapy.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Combination Antiretroviral Therapy and the Risk of Myocardial Infarction. The Data Collection o­n Adverse Events of Anti-HIV Drugs for the D:A:D Study Group.

    Friis-Møller, N., Sabin, C., Weber, R., Monforte, A. D., El-Sadr, W., Reiss, P., Thiebaut, R., Morfeldt, L., Wit, S. D., Pradier, C., Calvo, G., Law, M., Kirk, O., Phillips, A. & Lundgren, Jens, 2003, In: New England Journal of Medicine.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load.

    Arnaiz, J., Mallolas, J., Podzamczer, D., Gerstoft, J., Lundgren, Jens, Cahn, P., Fätkenheuer, G., Monforte, A. D., Casiró, A., Reiss, P., Burger, D., Stek, M. & Gatell, J., 2003, In: AIDS.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Decline in the AIDS and death rates in the EuroSIDA study: an observational study.

    Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., Monforte, A. D., Knysz, B., Dietrich, M., Phillips, A. & Lundgren, Jens, 2003, In: Lancet.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Dyslipidaemia and cardiovascular disease risk associated with antiretroviral drugs.

    Lundgren, Jens, 2003, In: Pharmacoepidemiology and Drug Safety.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study

    Florence, E., Lundgren, Jens, Dreezen, C., Fisher, M., Kirk, O., Blaxhult, A., Panos, G., Katlama, C., Vella, S. & Phillips, A., 2003, In: HIV Medicine.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    K65R with and withourt S68: A new resistance profile in vivo detected in most patients failing abacavir, didanosine and stavudine.

    Røge, B., Katzenstein, T., Obel, N., Pedersen, C., Mathiesen, L. R., Lundgren, Jens & Gerstoft, J., 2003, In: Antiviral Therapy.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Low efficacy and high frequency of adverse event in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.

    Gerstoft, J., Kirk, O., Obel, N., Pedersen, C., Mathiesen, L. R., Nielsen, H., Katzenstein, T. & Lundgren, Jens, 2003, In: AIDS.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Modelling the three year risk of myocardial infarction among participants in the D:A:D study

    Law, M., Friis-Møller, N., Weber, R., Reiss, P., Thiebaut, R., Kirk, O., Monforte, A. D., Pradier, C., Morfeldt, L., Calvo, G., El-Sadr, W., Wit, S. D., Sabin, C. & Lundgren, Jens, 2003, In: HIV Medicine.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    Monitoring of long-term toxicities of HIV treatments: an international perspective

    Bisson, G., Gross, R., Miller, V., Weller, I., Walker, A., Arlett, P., Carr, A., Evans, S., Graham, D., Justice, A., Kreft-Jais, C., Lundgren, Jens, Munk, B., Murray, J., Pirmohamed, M., Pizutti, D. & Szarfman, A., 2003, In: AIDS.

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Published

    Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies

    Chene, G., Sterne, J., May, M., Costagliola, D., Ledergerber, B., Phillips, A., Dabis, F., Lundgren, Jens, Monforte, A. D., Wolf, F. D., Hogg, R., Reiss, P., Justice, A., Leport, C., Staszewski, S., Gill, J., Fätkenheuer, G. & Egger, M., 2003, In: Lancet.

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial.

    Dragsted, U. B., Gerstoft, J., Pedersen, C., Peters, B., Duran, A., Obel, N., Castagna, A., Cahn, P., Clumeck, N., Bruun, J. N., Benetucci, J., Hill, A., Cassetti, I., Vernazza, P., Youle, M., Fox, Z. & Lundgren, Jens, 2003, In: Journal of Infectious Diseases. 188, 5, p. 635-642 8 p.

    Research output: Contribution to journal › Journal article › Research

  18. Published

    Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisited.

    Moore, A., Kirk, O., Johnson, A., Katlama, C., Blaxhult, A., Dietrich, M., Colebunders, R., Chiesi, A., Lundgren, Jens & Phillips, A., 2003, In: J A I D S.

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    Virological rebound after suppression o­n highly active antiretroviral therapy.

    Mocroft, A., Ruiz, L., Reiss, P., Ledergerber, B., Katlama, C., Lazzarin, A., Goebel, F., Phillips, A., Clotet, B. & Lundgren, Jens, 2003, In: AIDS.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 13961